Capital Fund Management (CFM) Portfolio holdings
AUM
$9.06B
1-Year Return
3.46%
This Quarter Return
+2.85%
1 Year Return
+3.46%
3 Year Return
+12.89%
5 Year Return
+19.14%
10 Year Return
+34.42%
AUM
$4.53B
AUM Growth
+$501M
(+12%)
Cap. Flow
+$262M
Cap. Flow
% of AUM
5.8%
Top 10 Holdings %
Top 10 Hldgs %
18.5%
Holding
937
New
151
Increased
202
Reduced
165
Closed
181
Top Buys
| 1 |
Amazon
AMZN
|
+$82.7M |
| 2 |
GE Aerospace
GE
|
+$56.5M |
| 3 |
Coca-Cola
KO
|
+$53.2M |
| 4 |
Johnson & Johnson
JNJ
|
+$45.3M |
| 5 |
iShares MSCI EAFE ETF
EFA
|
+$43.7M |
Top Sells
| 1 |
Tesla
TSLA
|
+$111M |
| 2 |
Marathon Petroleum
MPC
|
+$55M |
| 3 |
Intel
INTC
|
+$52.7M |
| 4 |
Microsoft
MSFT
|
+$50.3M |
| 5 |
Visa
V
|
+$46.7M |
Sector Composition
| 1 | Technology | 20.8% |
| 2 | Consumer Discretionary | 15.77% |
| 3 | Healthcare | 11.91% |
| 4 | Industrials | 9.2% |
| 5 | Communication Services | 8.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
451
Equinor
EQNR
$62.9B
| $807K | 0.01% |
22,534
-82,086
| -78% | -$2.94M |
|
452
EPR Properties
EPR
$4.19B
| $805K | 0.01% |
+21,354
| New | +$805K |
|
453
Mondelez International
MDLZ
$80.6B
| $805K | 0.01% |
12,072
-1,633
| -12% | -$109K |
|
454
Norwegian Cruise Line
NCLH
$11.5B
| $797K | 0.01% |
65,084
+13,079
| +25% | +$160K |
|
455
Albertsons Companies
ACI
$10.4B
| $774K | 0.01% |
37,331
-303,653
| -89% | -$6.3M |
|
456
Restaurant Brands International
QSR
$20.3B
| $760K | 0.01% |
+11,753
| New | +$760K |
|
457
Canadian Imperial Bank of Commerce
CM
$73.3B
| $753K | 0.01% |
18,616
-11,503
| -38% | -$465K |
|
|
LAC
458
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $741K | 0.01% |
39,109
-27,161
| -41% | -$515K |
|
459
Veracyte
VCYT
$2.42B
| $739K | 0.01% |
31,141
-41,921
| -57% | -$995K |
|
460
Dolby
DLB
$6.8B
| $736K | ﹤0.01% |
+10,435
| New | +$736K |
|
461
Pultegroup
PHM
$26.7B
| $710K | ﹤0.01% |
15,603
-111,031
| -88% | -$5.06M |
|
462
Matsons
MATX
$3.28B
| $698K | ﹤0.01% |
11,167
-34,434
| -76% | -$2.15M |
|
463
Arch Capital
ACGL
$33.8B
| $684K | ﹤0.01% |
+10,900
| New | +$684K |
|
464
Popular Inc
BPOP
$8.45B
| $673K | ﹤0.01% |
+10,153
| New | +$673K |
|
465
Perrigo
PRGO
$3.04B
| $672K | ﹤0.01% |
19,724
+2,922
| +17% | +$99.6K |
|
466
Lumentum
LITE
$11.5B
| $670K | ﹤0.01% |
+12,834
| New | +$670K |
|
467
Apellis Pharmaceuticals
APLS
$3.29B
| $666K | ﹤0.01% |
+12,884
| New | +$666K |
|
468
Masco
MAS
$15.3B
| $663K | ﹤0.01% |
14,212
-999
| -7% | -$46.6K |
|
469
Unum
UNM
$12.6B
| $662K | ﹤0.01% |
+16,123
| New | +$662K |
|
470
Fifth Third Bancorp
FITB
$30.1B
| $660K | ﹤0.01% |
+20,121
| New | +$660K |
|
471
Sealed Air
SEE
$4.83B
| $633K | ﹤0.01% |
12,684
-12,769
| -50% | -$637K |
|
|
SAGE
472
DELISTED
Sage Therapeutics
SAGE
| $629K | ﹤0.01% |
16,489
+5,340
| +48% | +$204K |
|
473
Mr. Cooper
COOP
$14B
| $628K | ﹤0.01% |
15,656
-7,881
| -33% | -$316K |
|
474
TG Therapeutics
TGTX
$5.05B
| $621K | ﹤0.01% |
+52,470
| New | +$621K |
|
475
Ultragenyx Pharmaceutical
RARE
$3.02B
| $617K | ﹤0.01% |
13,317
-37,649
| -74% | -$1.74M |
|